Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of 90Y-DOTA-hLL2 as a Consolidation Therapy After R-CHOP in Patients With Diffuse Large B-cell Lymphoma
This study has been terminated.
( completed recruitment of patients on 15 december 2010 : last patients included are in treatment phase the other patients in follow up period )
Study NCT00906841   Information provided by Groupe Ouest Est d'Etude des Leucémies et Autres Maladies du Sang GOELAMS

First Received on May 18, 2009.   Last Updated on January 25, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
B-cell Lymphoma
Additional conditions recognized in this trial
Lymphoma
Lymphoma, B-Cell
Lymphoma, Large B-Cell, Diffuse
More general conditions related to this trial
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoma, Non-Hodgkin
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Interventions listed in this trial
90Y-DOTA-hLL2
Sponsors listed in this trial
Groupe Ouest Est d'Etude des Leucémies et Autres Maladies du Sang GOELAMS


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services